美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Parabilis Medicines

36.16

-0.7200-1.95%

盤後：36.160.00000.00%19:53 EDT

成交量：48.24萬

成交額：1,747.68萬

市值：44.84億

市盈率：-1.54

高：37.58

開：37.06

低：35.60

收：36.88

52周最高：41.49

52周最低：24.51

股本：1.24億

流通股本：3,350.00萬

量比：0.97

換手率：1.44%

股息：- -

股息率：- -

每股收益(TTM):-23.4458

每股收益(LYR):-60.0402

淨資產收益率：--

總資產收益率：--

市淨率：4.28

市盈率(LYR):-0.60

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Parabilis Medicines

交易所：

NASDAQ

成立時間：

2015

員工人數：

145

公司地址：

30 Acorn Park Drive,Cambridge,Massachusetts,United States

官網：

http://www.parabilismed.com

郵編：

02140

電話：

傳真：

- -

簡介：

Parabilis Medicines, Inc.於2015年7月10日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，旨在開發變革性藥物，解決歷史上驅動人類疾病的不可藥物蛋白靶點。其專有平台開創了Helicons，穩定的螺旋肽被設計用於細胞滲透，能夠以高特異性結合扁平的細胞內蛋白質目標表面。

董事

名稱

職位

Mathai Mammen

Chairman and Chief Executive Officer and Director and President

Alan M. Sebulsky

Director

Alexis Borisy

Director

Barbara Weber

Director

Edward Fitzgerald

Director

Jake Simson

Director

Krishna Yeshwant

Director

Rick Klausner

Director

股東

名稱

職位

Mathai Mammen

Chairman and Chief Executive Officer and Director and President

Thomas Kotarakos

Chief Financial Officer

Fawzi Benzaghou

Chief Medical Officer

Helen Ho

Chief Business Officer and Chief Strategy Officer

Rohin Mhatre

Chief Technical Operations Officer

Teresa Jurgensen

General Counsel

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/PBLS/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":36.16,"timestamp":1789416000000,"preClose":36.88,"halted":0,"volume":482361,"hourTrading":{"tag":"盘后","latestPrice":36.16,"preClose":36.16,"latestTime":"19:53 EDT","volume":1161,"amount":41986.52,"timestamp":1789429990404,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019522776572668273,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"未開盤","change":-0.72,"latestTime":"09-14 16:00:00 EDT","open":37.06,"high":37.5766,"low":35.595,"amount":17476755.667173,"amplitude":0.053731,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":36.88,"preHourTrading":{"tag":"盘前","latestPrice":37,"preClose":36.88,"latestTime":"09:12 EDT","volume":1083,"amount":42350.028377999995,"timestamp":1789391554623,"change":0.12,"changeRate":0.003254,"amplitude":0.094631},"postHourTrading":{"tag":"盘后","latestPrice":36.16,"preClose":36.16,"latestTime":"19:53 EDT","volume":1161,"amount":41986.52,"timestamp":1789429990404,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.967671,"impliedVol":0.677,"impliedVolPercentile":0.6098},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":0.967671,"shares":124000000,"dividePrice":0,"high":37.5766,"amplitude":0.053731,"preClose":36.88,"low":35.595,"week52Low":24.51,"pbRate":"4.28","psRate":"30296.22","week52High":41.4899,"institutionHeld":0,"latestPrice":36.16,"eps":-23.44581,"divideRate":0,"volume":482361,"delay":0,"ttmEps":-23.44581,"open":37.06,"prevYearClose":20,"prevWeekClose":36.88,"prevMonthClose":39.01,"prevQuarterClose":27.37,"fiveDayClose":40.42,"twentyDayClose":37.07,"sixtyDayClose":26.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-09-11","current":-1.54228,"percent":0.52381,"low":-31.159897,"twenty":-28.726773,"median":-26.487161,"eighty":-23.303097,"high":-15.535256,"avg":-26.148415,"sd":2.96,"marketCap":4486727276},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639},{"date":"2026-08-28","current":-28.461644,"twenty":-28.506557,"median":-25.662561,"eighty":-22.933884,"marketCap":4853620999},{"date":"2026-09-04","current":-29.519266,"twenty":-28.607972,"median":-26.20813,"eighty":-23.085477,"marketCap":5033979530},{"date":"2026-09-11","current":-26.310178,"twenty":-28.726773,"median":-26.487161,"eighty":-23.303097,"marketCap":4486727276}],"updateTime":1789420189636},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":316822253,"yearFounded":2015,"employeeNum":145,"address":"30 Acorn Park Drive,Cambridge,Massachusetts,United States","zipCode":"02140","officePhone":"(617) 945-9510","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.parabilismed.com","stockEarnings":[{"period":"1week","weight":-0.0876},{"period":"1month","weight":-0.0142},{"period":"3month","weight":0.3529},{"period":"6month","weight":0.844},{"period":"ytd","weight":0.844}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Parabilis Medicines, Inc.於2015年7月10日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，旨在開發變革性藥物，解決歷史上驅動人類疾病的不可藥物蛋白靶點。其專有平台開創了Helicons，穩定的螺旋肽被設計用於細胞滲透，能夠以高特異性結合扁平的細胞內蛋白質目標表面。","exchange":"NASDAQ","name":"Parabilis Medicines","nameEN":"Parabilis Medicines"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":{"directors":[{"name":"Mathai Mammen","position":"Chairman and Chief Executive Officer and Director and President"},{"name":"Alan M. Sebulsky","position":"Director"},{"name":"Alexis Borisy","position":"Director"},{"name":"Barbara Weber","position":"Director"},{"name":"Edward Fitzgerald","position":"Director"},{"name":"Jake Simson","position":"Director"},{"name":"Krishna Yeshwant","position":"Director"},{"name":"Rick Klausner","position":"Director"}],"executives":[{"name":"Mathai Mammen","position":"Chairman and Chief Executive Officer and Director and President"},{"name":"Thomas Kotarakos","position":"Chief Financial Officer"},{"name":"Fawzi Benzaghou","position":"Chief Medical Officer"},{"name":"Helen Ho","position":"Chief Business Officer and Chief Strategy Officer"},{"name":"Rohin Mhatre","position":"Chief Technical Operations Officer"},{"name":"Teresa Jurgensen","position":"General Counsel"}]}}}